CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,455,205 | -22.3% | 803,155 | -3.9% | 0.01% | -20.0% |
| Q2 2023 | $46,914,233 | +67.0% | 835,665 | +34.5% | 0.01% | +42.9% |
| Q1 2023 | $28,098,640 | -34.1% | 621,239 | -40.8% | 0.01% | -30.0% |
| Q4 2022 | $42,662,744 | -41.9% | 1,049,514 | -6.6% | 0.01% | -37.5% |
| Q3 2022 | $73,427,000 | -13.8% | 1,123,590 | -19.9% | 0.02% | -27.3% |
| Q2 2022 | $85,224,000 | +17.1% | 1,402,408 | +20.9% | 0.02% | +46.7% |
| Q1 2022 | $72,801,000 | -3.9% | 1,159,813 | +16.1% | 0.02% | -6.2% |
| Q4 2021 | $75,721,000 | -31.2% | 999,219 | +1.7% | 0.02% | -30.4% |
| Q3 2021 | $109,996,000 | -24.0% | 982,721 | +9.9% | 0.02% | -30.3% |
| Q2 2021 | $144,783,000 | +20.0% | 894,334 | -9.7% | 0.03% | +13.8% |
| Q1 2021 | $120,653,000 | +36.1% | 990,173 | +71.0% | 0.03% | +26.1% |
| Q4 2020 | $88,676,000 | +395.7% | 579,164 | +170.8% | 0.02% | +360.0% |
| Q3 2020 | $17,888,000 | +0.4% | 213,873 | -11.7% | 0.01% | -16.7% |
| Q2 2020 | $17,808,000 | +111.0% | 242,305 | +21.8% | 0.01% | +20.0% |
| Q1 2020 | $8,438,000 | -63.8% | 198,949 | -48.0% | 0.01% | -50.0% |
| Q4 2019 | $23,325,000 | +301.6% | 382,958 | +170.3% | 0.01% | +233.3% |
| Q3 2019 | $5,808,000 | -12.5% | 141,700 | +0.6% | 0.00% | 0.0% |
| Q2 2019 | $6,636,000 | +51.3% | 140,900 | +14.7% | 0.00% | +50.0% |
| Q1 2019 | $4,387,000 | -28.0% | 122,800 | -42.4% | 0.00% | -50.0% |
| Q4 2018 | $6,094,000 | -14.2% | 213,308 | +33.2% | 0.00% | 0.0% |
| Q3 2018 | $7,104,000 | -54.3% | 160,175 | -39.4% | 0.00% | -50.0% |
| Q2 2018 | $15,534,000 | +117.4% | 264,381 | +69.2% | 0.01% | +100.0% |
| Q1 2018 | $7,144,000 | +664.1% | 156,296 | +292.6% | 0.00% | +300.0% |
| Q4 2017 | $935,000 | – | 39,811 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |